Exchange: NASDAQ·Updated 07:58 PM EDT
NRSN logo

NRSN NeuroSense Therapeutics Ltd

$0.5108
$0.1092
(27.19%)
Today
Closed $0.5108
$0.0209
(4.09%)
After Hours
Mkt Cap$15.17M
Vol4.22M

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). It also conducts testing of product candidates for the treatment of Parkinson's and Alzheimer's diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
86

Extremely Bullish Sentiment

How do you feel about NRSN?

Advertisement|Remove ads.